Literature DB >> 9151233

In vivo diagnosis of human malignant melanoma with positron emission tomography using specific melanoma-seeking 18F-DOPA analogue.

Y Mishima1, Y Imahori, C Honda, J Hiratsuka, S Ueda, T Ido.   

Abstract

Detection and diagnosis of human malignant melanoma by Positron Emission Tomography (PET) using 18F-10B-L-BPA, a specific melanogenesis-seeking compound synthesized for use in Boron Neutron Capture Therapy for malignant melanoma (NCT), has been developed. This resulted in a novel, highly effective methodology for the selective three dimensional imaging of metastatic malignant melanomas, and for accurate determination of 10B concentration in the tumor and surrounding tissue, providing almost all diagnostic information necessary for complete non-invasive radiation dose planning in the treatment of malignant melanoma both for NCT as well as other therapeutic modalities.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9151233     DOI： 10.1023/a:1005746020350

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  12 in total

1.  Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin.

Authors:  M E Phelps; S C Huang; E J Hoffman; D E Kuhl
Journal:  J Nucl Med       Date:  1979-04       Impact factor: 10.057

Review 2.  Estimation of absorbed doses in human malignant melanoma treated by neutron capture therapy with special references to vertical direction.

Authors:  T Kobayashi; S Hatta; C Honda; K Yamamura; T Akiyoshi; K Kanda; Y Mishima
Journal:  Pigment Cell Res       Date:  1989 Jul-Aug

3.  Modeling metabolic processes in the brain in vivo.

Authors:  L Sokoloff
Journal:  Ann Neurol       Date:  1984       Impact factor: 10.422

4.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

5.  4-Borono-2-[18F]fluoro-D,L-phenylalanine: a possible tracer for melanoma diagnosis with PET.

Authors:  K Ishiwata; T Ido; C Honda; M Kawamura; M Ichihashi; Y Mishima
Journal:  Int J Rad Appl Instrum B       Date:  1992-04

6.  Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound.

Authors:  Y Mishima; C Honda; M Ichihashi; H Obara; J Hiratsuka; H Fukuda; H Karashima; T Kobayashi; K Kanda; K Yoshino
Journal:  Lancet       Date:  1989-08-12       Impact factor: 79.321

7.  4-Borono-2-[18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography.

Authors:  K Ishiwata; T Ido; M Kawamura; K Kubota; M Ichihashi; Y Mishima
Journal:  Int J Rad Appl Instrum B       Date:  1991

8.  A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine.

Authors:  K Ishiwata; M Shiono; K Kubota; K Yoshino; J Hatazawa; T Ido; C Honda; M Ichihashi; Y Mishima
Journal:  Melanoma Res       Date:  1992-09       Impact factor: 3.599

9.  Noninvasive determination of local cerebral metabolic rate of glucose in man.

Authors:  S C Huang; M E Phelps; E J Hoffman; K Sideris; C J Selin; D E Kuhl
Journal:  Am J Physiol       Date:  1980-01

10.  Treatment of malignant melanoma by selective thermal neutron capture therapy using melanoma-seeking compound.

Authors:  Y Mishima; M Ichihashi; M Tsuji; S Hatta; M Ueda; C Honda; T Suzuki
Journal:  J Invest Dermatol       Date:  1989-05       Impact factor: 8.551
View more
  6 in total

1.  Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas.

Authors:  Minoru Miyashita; Shin-Ichi Miyatake; Yoshio Imahori; Kunio Yokoyama; Shinji Kawabata; Yoshinaga Kajimoto; Masa-Aki Shibata; Yoshinori Otsuki; Mitsunori Kirihata; Koji Ono; Toshihiko Kuroiwa
Journal:  J Neurooncol       Date:  2008-06-20       Impact factor: 4.130

2.  Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas.

Authors:  Shin-Ichi Miyatake; Shinji Kawabata; Naosuke Nonoguchi; Kunio Yokoyama; Toshihiko Kuroiwa; Hideki Matsui; Koji Ono
Journal:  Neuro Oncol       Date:  2009-03-16       Impact factor: 12.300

Review 3.  A critical assessment of boron target compounds for boron neutron capture therapy.

Authors:  M Frederick Hawthorne; Mark W Lee
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

4.  Cerebral melanoma metastases: a critical review on diagnostic methods and therapeutic options.

Authors:  Carlos R Goulart; Tobias Alecio Mattei; Ricardo Ramina
Journal:  ISRN Surg       Date:  2011-05-25

5.  FBPA PET in boron neutron capture therapy for cancer: prediction of (10)B concentration in the tumor and normal tissue in a rat xenograft model.

Authors:  Kohei Hanaoka; Tadashi Watabe; Sadahiro Naka; Yasukazu Kanai; Hayato Ikeda; Genki Horitsugi; Hiroki Kato; Kayako Isohashi; Eku Shimosegawa; Jun Hatazawa
Journal:  EJNMMI Res       Date:  2014-12-20       Impact factor: 3.138

6.  Reliable radiosynthesis of 4-[10B]borono-2-[18F]fluoro-L-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis.

Authors:  Kiichi Ishiwata; Ryoichi Ebinuma; Chuichi Watanabe; Kunpei Hayashi; Jun Toyohara
Journal:  Ann Nucl Med       Date:  2018-06-05       Impact factor: 2.668
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.